Literature DB >> 19797708

Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort.

Anna M Kucharska-Newton1, David J Couper, James S Pankow, Ronald J Prineas, Thomas D Rea, Nona Sotoodehnia, Aravinda Chakravarti, Aaron R Folsom, David S Siscovick, Wayne D Rosamond.   

Abstract

OBJECTIVE: This study examines the hypothesis that chronic inflammation is associated with a higher risk of cardiac death compared to the risk of nonfatal myocardial infarction. METHODS AND
RESULTS: Cardiac death and nonfatal MI events were identified in the ARIC cohort during follow-up from 1987 through 2001. Markers of inflammation and hemostasis were determined at baseline using standardized procedures. Cox proportional hazard regression and polytomous logistic regression were used to estimate associations. We observed a positive gradient in incidence of sudden cardiac death (SCD), nonsudden cardiac death (NSCD), and nonfatal MI in association with decreasing levels of albumin and increasing levels of white blood cell count and of markers of hemostasis (fibrinogen, von Willebrand factor, factor VIIIc). Associations for von Willebrand factor were stronger for fatal relative to nonfatal events (3rd versus 1st tertile hazard ratios: SCD 3.11 [95% CI 2.10, 4.59], NSCD 2.12 [95% CI 1.28, 3.49], nonfatal MI 1.42 [95% CI 1.19, 1.70]). For factor VIIIc those associations were strongest for sudden cardiac death: SCD 3.16 (95% CI 2.18, 4.58), NSCD 1.44 (95% CI 0.93, 2.24), nonfatal MI 1.54 (95% CI 1.29, 1.84). Gradients of association for fibrinogen and white blood cell count, examined over tertiles of distribution and per one SD increase, were similar for the 3 end points. All associations were independent of smoking status.
CONCLUSIONS: von Willebrand factor and factor VIIIc are associated with an increased risk of cardiac death as compared to the risk of nonfatal MI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19797708      PMCID: PMC3057473          DOI: 10.1161/ATVBAHA.109.192740

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  40 in total

1.  Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Folsom; N Aleksic; E Park; V Salomaa; H Juneja; K K Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

Review 2.  Hemostatic risk factors for atherothrombotic disease: an epidemiologic view.

Authors:  A R Folsom
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

Review 3.  High-sensitivity C-reactive protein: clinical importance.

Authors:  Shari S Bassuk; Nader Rifai; Paul M Ridker
Journal:  Curr Probl Cardiol       Date:  2004-08       Impact factor: 5.200

4.  Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  J J Nelson; D Liao; A R Sharrett; A R Folsom; L E Chambless; E Shahar; M Szklo; J Eckfeldt; G Heiss
Journal:  Am J Epidemiol       Date:  2000-03-01       Impact factor: 4.897

5.  White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study.

Authors:  C D Lee; A R Folsom; F J Nieto; L E Chambless; E Shahar; D A Wolfe
Journal:  Am J Epidemiol       Date:  2001-10-15       Impact factor: 4.897

Review 6.  Endothelial dysfunction: a marker of atherosclerotic risk.

Authors:  Piero O Bonetti; Lilach O Lerman; Amir Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

Review 7.  Inflammation and atherosclerosis.

Authors:  Peter Libby; Paul M Ridker; Attilio Maseri
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

8.  Hemostatic factors as predictors of coronary events and total mortality: The FINRISK '92 Hemostasis Study.

Authors:  Veikko Salomaa; Vesa Rasi; Sangita Kulathinal; Elina Vahtera; Matti Jauhiainen; Christian Ehnholm; Juha Pekkanen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-02-01       Impact factor: 8.311

9.  Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency.

Authors:  J Siedel; E O Hägele; J Ziegenhorn; A W Wahlefeld
Journal:  Clin Chem       Date:  1983-06       Impact factor: 8.327

10.  HDL cholesterol quantitation by phosphotungstate-Mg2+ and by dextran sulfate-Mn2+-polyethylene glycol precipitation, both with enzymic cholesterol assay compared with the lipid research method.

Authors:  G R Warnick; C Mayfield; J Benderson; J S Chen; J J Albers
Journal:  Am J Clin Pathol       Date:  1982-11       Impact factor: 2.493

View more
  16 in total

1.  Contrast ultrasound imaging of the aorta alters vascular morphology and circulating von Willebrand factor in hypercholesterolemic rabbits.

Authors:  Brendon W Smith; Douglas G Simpson; Sandhya Sarwate; Rita J Miller; James P Blue; Alexander Haak; William D O'Brien; John W Erdman
Journal:  J Ultrasound Med       Date:  2012-05       Impact factor: 2.153

Review 2.  Arterial thrombus formation in cardiovascular disease.

Authors:  Giuseppe Lippi; Massimo Franchini; Giovanni Targher
Journal:  Nat Rev Cardiol       Date:  2011-07-05       Impact factor: 32.419

3.  Systemic inflammation and circadian rhythm of cardiac autonomic modulation.

Authors:  Xian Li; Michele L Shaffer; Sol M Rodríguez-Colón; Fan He; Edward O Bixler; Alexandros N Vgontzas; Deborah L Wolbrette; Chuntao Wu; Richard W Ball; Duanping Liao
Journal:  Auton Neurosci       Date:  2011-03-27       Impact factor: 3.145

4.  Serum albumin and risk of cardiovascular events in primary and secondary prevention: a systematic review of observational studies and Bayesian meta-regression analysis.

Authors:  Pasquale Pignatelli; Alessio Farcomeni; Danilo Menichelli; Daniele Pastori; Francesco Violi
Journal:  Intern Emerg Med       Date:  2019-10-11       Impact factor: 3.397

5.  Plasma biomarkers for prediction of sudden cardiac death: another piece of the risk stratification puzzle?

Authors:  Rasmus Havmöller; Sumeet S Chugh
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-02

6.  Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities study.

Authors:  Selcuk Adabag; Rachel R Huxley; Faye L Lopez; Lin Y Chen; Nona Sotoodehnia; David Siscovick; Rajat Deo; Suma Konety; Alvaro Alonso; Aaron R Folsom
Journal:  Heart       Date:  2014-11-19       Impact factor: 5.994

7.  Association of the von Willebrand Factor-ADAMTS13 Ratio With Incident Cardiovascular Events in Patients With Peripheral Arterial Disease.

Authors:  David Green; Lu Tian; Philip Greenland; Kiang Liu; Melina Kibbe; Russell Tracy; Sanjiv Shah; John T Wilkins; Mark D Huffman; Yihua Liao; Donald Lloyd Jones; Mary M McDermott
Journal:  Clin Appl Thromb Hemost       Date:  2016-06-17       Impact factor: 2.389

Review 8.  Sudden Cardiac Death in Patients with Heart Disease and Preserved Systolic Function: Current Options for Risk Stratification.

Authors:  Luigi Pannone; Giulio Falasconi; Lorenzo Cianfanelli; Luca Baldetti; Francesco Moroni; Roberto Spoladore; Pasquale Vergara
Journal:  J Clin Med       Date:  2021-04-22       Impact factor: 4.241

9.  Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS).

Authors:  Neil A Zakai; Suzanne E Judd; Brett Kissela; George Howard; Monika M Safford; Mary Cushman
Journal:  Thromb Haemost       Date:  2018-06-11       Impact factor: 5.249

10.  Von Willebrand factor, ADAMTS13 and mortality in dialysis patients.

Authors:  Gurbey Ocak; Mark Roest; Marianne C Verhaar; Maarten B Rookmaaker; Peter J Blankestijn; Willem Jan W Bos; Rob Fijnheer; Nathalie C Péquériaux; Friedo W Dekker
Journal:  BMC Nephrol       Date:  2021-06-16       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.